Financial Results for Mar 31, 2011
Caplin Point Laboratories Ltd has informed BSE about the Financial Results for the period ended March 31, 2011.30-04-2011
30-04-2011
Outcome of Board Meeting
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors at their Meeting held on April 08, 2011, has approved the re-appointment of Mr. M. Jayapal as the Managing Director of the Company for a further period of one year w.e.f. March 28, 2011 on a revised remuneration upon the recommendation of the Audit Committee subject to approval of the shareholders at the ensuing General Meeting.18-04-2011
Reconstitution of Audit Committee
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors vide circular resolution passed on December 01, 2010 has approved the Reconstitution of the Audit Committee of the Board with the following members effective from December 01, 2010.1. Mr. V. Thirumalai: Chairman & Non-Executive Independent Director2. Mr. D. P. Mishra: Non-Executive Independent Director...07-02-2011
Financial Results for Dec 31, 2010
Caplin Point Laboratories Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010.07-02-2011
Outcome of AGM
Caplin Point Laboratories Ltd has informed BSE that the members at the 19th Annual General Meeting (AGM) of the Company held on December 28, 2010, inter alia, have passed the necessary resolution pertaining to the following:1. Adoption of accounts as at June 30, 2010.2. Declaration of Final Dividend at 10% (Re. 1/- per share) on the equity share capital of the Company....30-12-2010
Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997
P Vijayalakshmi has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE14-12-2010
Disclosures under Reg. 7(1A) of SEBI (SAST) Regulations, 1997
S Kirubakaran has submitted the disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE:14-12-2010
Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
C C Paarthipan has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE14-12-2010
Disclosures under Reg. 7(1A) of SEBI (SAST) Regulations, 1997
Indiraniammal has submitted the disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE:09-12-2010
Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997
Caplin Point Laboratories Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE:07-12-2010